A detailed history of Clearstead Advisors, LLC transactions in Inogen Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 28 shares of INGN stock, worth $193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 33 15.15%
Holding current value
$193
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$5.87 - $8.79 $29 - $43
-5 Reduced 15.15%
28 $0
Q2 2025

Aug 08, 2025

BUY
$5.75 - $7.32 $28 - $36
5 Added 17.86%
33 $0
Q1 2022

May 04, 2022

BUY
$28.1 - $35.25 $786 - $987
28 New
28 $1,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $158M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.